WAIS-R features of preclinical huntington's disease: Implications for early detection

Dementia and Geriatric Cognitive Disorders

Volumn 29, Issue 4, 2010, Pages 342-350

  Robins Wahlin, Tarja Brita ^a,b   Larsson, Maria U ^a   Luszcz, Mary A ^c   Byrne, Gerard J ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

Cognition; Executive functions; Huntington's disease; Intelligence; IQ; Neuropsychology; Preclinical; Wechsler Adult Intelligence Scale

Indexed keywords

ADULT; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPTH PERCEPTION; EARLY DIAGNOSIS; FEMALE; FRONTAL CORTEX; HUMAN; HUNTINGTON CHOREA; INTELLIGENCE; LANGUAGE ABILITY; MALE; MENTAL PERFORMANCE; ONSET AGE; PRIORITY JOURNAL; PROBLEM SOLVING; PSYCHOMOTOR PERFORMANCE; RATING SCALE; SCORING SYSTEM; THINKING; WECHSLER INTELLIGENCE SCALE;

ADULT; ATTENTION; COGNITION DISORDERS; EARLY DIAGNOSIS; FEMALE; HUMANS; HUNTINGTON DISEASE; INTELLIGENCE; LANGUAGE; LINEAR MODELS; MALE; MIDDLE AGED; PROBLEM SOLVING; PSYCHOMOTOR PERFORMANCE; SPACE PERCEPTION; THINKING; TIME FACTORS; VISUAL PERCEPTION; WECHSLER SCALES;

EID: 77950621018     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000288775     Document Type: Article

References (43)

1. Huntington's Disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971-983.
2. Bates G, Harper PS, Jones L: Huntington's disease, in Motulsky AG, Bobrow M, Harper PS, Scriver C (eds): Oxford Monographs on Medical Genetics 45, ed 3. Oxford, Oxford University Press, 2002
3. Snowden JS, Craufurd D, Thompson J, Neary D: Psychomotor, executive, and memory function in preclinical Huntington's disease. J Clin Exp Neuropsychol 2002; 24: 133-145.
4. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord 1996; 11: 136-142.
5. Kipps CM, Duggins AJ, Mahant N, Gomes L, Ashburner J, McCusker EA: Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. J Neurol Neurosurg Psychiatry 2005; 76: 650-655.
6. Tekin S, Cummings JL: Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002; 53: 647-654.
7. Ho AK, Sahakian BJ, Brown RG, Barker RA, Hodges JR, Ane MN, et al: Profile of cognitive progression in early Huntington's disease. Neurology 2003; 61: 1702-1706.
8. Andrews TC, Weeks RA, Turjanski N, Gunn RN, Watkins LH, Sahakian B, et al: Huntington's disease progression. PET and clinical observations. Brain 1999; 122: 2353-2363.
9. Bäckman L, Robins Wahlin T-B, Lundin A, Ginovart N, Farde L: Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain 1997; 120: 2207-2217.
10. Aylward EH, Sparks BF, Field KM, Yallapragada V, Shpritz BD, Rosenblatt A, et al: Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 2004; 63: 66-72.
11. Solomon AC, Stout JC, Johnson SA, Langbehn DR, Aylward EH, Brandt J, et al: Verbal episodic memory declines prior to diagnosis in Huntington's disease. Neuropsychologia 2007; 45: 1767-1776.
12. Foroud T, Siemers E, Kleindorfer D, Bill DJ, Hodes ME, Norton JA, et al: Cognitive scores in carriers of Huntington's disease gene compared to noncarriers. Ann Neurol 1995; 37: 657-664.
13. Jason GW, Suchowersky O, Pajurkova EM, Graham L, Klimek ML, Garber AT, et al: Cognitive manifestations of Huntington disease in relation to genetic structure and clinical onset. Arch Neurol 1997; 54: 1081-1088.
14. Kirkwood SC, Siemers E, Stout JC, Hodes ME, Conneally PM, Christian JC, et al: Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Arch Neurol 1999; 56: 563-568.
15. Kirkwood SC, Siemers E, Hodes ME, Conneally PM, Christian JC, Foroud T: Subtle changes among presymptomatic carriers of the Huntington's disease gene. J Neurol Neurosurg Psychiatry 2000; 69: 773-779.
16. Larsson MU, Almkvist O, Luszcz MA, Robins Wahlin T-B: Phonemic fluency deficits in asymptomatic gene carriers for Huntington's disease. Neuropsychology 2008; 22: 596-605.
17. Lawrence AD, Hodges JR, Rosser AE, Kershaw A, ffrench-Constant C, Rubinsztein DC, et al: Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 1998; 121: 1329-1341.
18. Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R: Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation - a longitudinal follow-up study. J Neurol 2004; 251: 935-942.
19. Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R: Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington's disease mutation after 1 year. Acta Neurol Scand 2002; 106: 131-141.
20. Robins Wahlin T-B, Lundin A, Dear K: Early cognitive deficits in Swedish gene carriers of Huntington's disease. Neuropsychology 2007; 21: 31-44.
21. Rosenberg NK, Sørensen SA, Christensen A-L: Neuropsychological characteristics of Huntington's disease carriers: a double blind study. J Med Genet 1995; 32: 600-604.
22. Siemers E, Foroud T, Bill DJ, Sorbel J, Norton JA Jr, Hodes ME, et al: Motor changes in presymptomatic Huntington disease gene carriers. Arch Neurol 1996; 53: 487-492.
23. Verny C, Allain P, Prudean A, Malinge MC, Gohier B, Scherer C, et al: Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene. Eur J Neurol 2007; 14: 1344-1350.
24. Blackmore L, Simpson SA, Crawford JR: Cognitive performance in UK sample of presymptomatic people carrying the gene for Huntington's disease. J Med Genet 1995; 32: 358-362.
25. Campodonico JR, Codori AM, Brandt J: Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation. J Neurol 1996; 61: 621-624.
26. de Boo GM, Tibben A, Lanser JB, Jennekens-Schinkel A, Hermans J, Maat-Kievit A, et al: Early cognitive and motor symptoms in identified carriers of the gene for Huntington disease. Arch Neurol 1997; 54: 1353-1357.
27. de Boo GM, Tibben A, Hermans J, Jennekens- Schinkel A, Maat-Kievit A, Roos RAC: Memory and learning are not impaired in presymptomatic individuals with an increased risk of Huntington's disease. J Clin Exp Neuropsychol 1999; 21: 284-290.
28. Giordani B, Berent S, Boivin MJ, Penney JB, Lehtinen S, Markel DS, et al: Longitudinal neuropsychological and genetic linkage analysis of persons at risk for Huntington's disease. Arch Neurol 1995; 52: 59-64.
29. Soliveri P, Monza D, Piacentini S, Paridi D, Nespolo C, Gellera C, et al: Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives. Neurol Sci 2002; 23(suppl 2):S105-S106.
30. Witjes-Ane MN, Mertens B, van Vugt JP, Bachoud- Levi AC, van Ommen GJ, Roos RA: Longitudinal evaluation of 'presymptomatic' carriers of Huntington's disease. J Neuropsychiatry Clin Neurosci 2007; 19: 310-317.
31. DeKosky ST, Marek K: Looking backward to move forward: early detection of neurodegenerative disorders. Science 2003; 302: 830-834.
32. Nopoulos P, Magnotta VA, Mikos A, Paulson H, Andreasen NC, Paulsen JS: Morphology of the cerebral cortex in preclinical Huntington's disease. Am J Psychiatry 2007; 164: 1428-1434.
33. de Boo GM, Tibben A, Lanser JB, Jennekens- Schinkel A, Hermans J, Vegter-van der Vlis M, et al: Intelligence indices in people with a high/low risk for developing Huntington's disease. J Med Genet 1997; 34: 564-568.
34. Johnson SA, Stout JC, Solomon AC, Langbehn DR, Aylward EH, Cruce CB, et al: Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease. Brain 2007; 130: 1732-1744.
35. Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, et al: Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 2008; 79: 874-880.
36. Berrios GE, Wagle AC, Markova IS, Wagle SA, Rosser A, Hodges JR: Psychiatric symptoms in neurologically asymptomatic Huntington's disease gene carriers: a comparison with gene negative at risk subjects. Acta Psychiatr Scand 2002; 105: 224-230.
37. Lyle OE, Gottesman II: Premorbid psychometric indicators of the gene for Huntington's disease. J Consult Clin Psychol 1977; 45: 1011-1022.
38. Strauss ME, Brandt J: Is there increased WAIS pattern variability in HD? J Clin Exp Neuropsychol 1984; 7: 122-126.
39. Josiassen RC, Curry L, Mancall EL: Development of neuropsychological deficits in Huntington's disease. Arch Neurol 1983; 40: 791-796.
40. Wechsler D: WAIS-R: Manual: Wechsler Adult Intelligence Scale - Revised (WAISR). New York, The Psychological Corporation, Harcourt Brace Jovanovich, 1981.
41. Wechsler D: Manual for the Wechsler Adult Intelligence Scale - Revised Swedish Edition. Stockholm, Psykologitörlaget, 1994.
42. Josiassen RC, Curry L, Roemer RA, DeBease C, Mancall EL: Patterns of intellectual deficit in Huntington's disease. J Clin Neuropsychol 1982; 4: 173-183.
43. Strauss ME, Brandt J: Are there neuropsychologic manifestations of the gene for Huntington's disease in asymptomatic, at risk individuals. Arch Neurol 1990; 47: 905-908.